Investing Profile

Michal Silverberg

VC
Managing Director at Novartis Venture Fund -NVF
Photo of Michal Silverberg, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
3
$750M
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DAug 2023$75M
$130M
Co-investors: Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Matthew Foy (SR One), Chandra Leo (Hbm Partners), Ran Nussbaum (Pontifax Venture Capital)
Twentyeight-Seven Therapeutics
Series AMay 2019$15M
Series ASep 2018$65M
$80M
Co-investors: Kazumi Shiosaki (MPM Capital), Henrijette Richter (Soffinova Partners)